The US regulator is proposing to restrict the use of sunlamp products to adults aged 18 and over as a safety measure to cut rates of eye injury, skin damage and skin cancer.
Tag: Regulatory Affairs / Drug Approvals
Health Canada approves JETREA® for the treatment of symptomatic vitreomacular adhesion
ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, has announced that Health Canada has approved JETREA(R) (ocriplasmin) for the treatment of sym…